Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2440934
Max Phase: Preclinical
Molecular Formula: C36H46F3N7O6
Molecular Weight: 615.78
Molecule Type: Small molecule
Associated Items:
ID: ALA2440934
Max Phase: Preclinical
Molecular Formula: C36H46F3N7O6
Molecular Weight: 615.78
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: NCCCCCCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1.O=C(O)C(F)(F)F
Standard InChI: InChI=1S/C34H45N7O4.C2HF3O2/c35-21-9-1-2-10-22-38-34(45)41-33(36)37-23-11-16-29(31(43)39-24-25-17-19-28(42)20-18-25)40-32(44)30(26-12-5-3-6-13-26)27-14-7-4-8-15-27;3-2(4,5)1(6)7/h3-8,12-15,17-20,29-30,42H,1-2,9-11,16,21-24,35H2,(H,39,43)(H,40,44)(H4,36,37,38,41,45);(H,6,7)/t29-;/m1./s1
Standard InChI Key: OXYALBKRGGKVQU-XXIQNXCHSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 615.78 | Molecular Weight (Monoisotopic): 615.3533 | AlogP: 3.24 | #Rotatable Bonds: 17 |
Polar Surface Area: 183.96 | Molecular Species: BASE | HBA: 5 | HBD: 7 |
#RO5 Violations: 2 | HBA (Lipinski): 11 | HBD (Lipinski): 9 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 9.41 | CX Basic pKa: 10.28 | CX LogP: 2.03 | CX LogD: -1.25 |
Aromatic Rings: 3 | Heavy Atoms: 45 | QED Weighted: 0.07 | Np Likeness Score: -0.17 |
1. Keller M, Kaske M, Holzammer T, Bernhardt G, Buschauer A.. (2013) Dimeric argininamide-type neuropeptide Y receptor antagonists: chiral discrimination between Y1 and Y4 receptors., 21 (21): [PMID:24074877] [10.1016/j.bmc.2013.08.065] |
Source(1):